Jane Street’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Jane Street’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-7,398	Closed	-$33K	–	4882
2016 Q2	$33K	Buy	+7,398	New	+$48.3K	﹤0.01%	3975
2015 Q3	–	Sell	-1,625	Closed	-$96K	–	4518
2015 Q2	$96K	Buy	+1,625	New	+$115K	﹤0.01%	3439
2014 Q3	–	Sell	-6,184	Closed	-$555K	–	3406
2014 Q2	$555K	Buy	6,184 +4,071	+193%	+$249K	0.01%	1325
2014 Q1	$113K	Buy	+2,113	New	+$69.7K	﹤0.01%	2499

Other funds holding PTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Jane Street's PTX Position: Q3 2016 in Review

Jane Street sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q3 2016, closing a stake of 7,398 shares — an estimated $33K sold.

Jane Street first reported a position in PTX in Q1 2014 and held it in 4 quarters. The position peaked at $555K in Q2 2014. 48 funds tracked by Wall St. Rank hold PTX as of Q3 2016.

Jane Street reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q3 2016 after selling out during the quarter.
Jane Street sold 7,398 Pernix Therapeutics Holdings, Inc. shares in Q3 2016, an estimated $33K.
Jane Street first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2014 and held it in 4 quarters.
Jane Street's Pernix Therapeutics Holdings, Inc. position peaked at $555K in Q2 2014.
48 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q3 2016.

Based on Jane Street's 13F filing for Q3 2016, filed 15 Nov 2016.